<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01141192</url>
  </required_header>
  <id_info>
    <org_study_id>0910091</org_study_id>
    <nct_id>NCT01141192</nct_id>
  </id_info>
  <brief_title>The Effect of Vitamin D Supplementation on Glucose Metabolism in Non-Diabetic African American Adults</brief_title>
  <acronym>AVIS</acronym>
  <official_title>The Effect of Vitamin D Supplementation on Glucose Metabolism in Non-Diabetic African American Adults</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Augusta University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Augusta University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Type 2 diabetes is more common among African Americans than Caucasians. African Americans are
      also at a higher risk for lower levels of vitamin D compared to other ethnic groups. The
      investigators don't yet know if there is a connection between not having enough vitamin D and
      type 2 diabetes in African Americans. Researchers have found that the less vitamin D
      Caucasians had the higher the chance they would have type 2 diabetes but it is less clear if
      this is the case for African Americans. The investigators want to better understand how
      vitamin D status and diabetes risk are linked in African Americans. Also, the investigators
      want to see if supplementation with vitamin D will improve your blood pressure, blood sugar,
      &amp; insulin. All of these are in some way related to diabetes. The investigators want to
      measure changes in blood sugar &amp; blood pressure in people who do not have diabetes with the
      hope of learning new information to help treat those that do have diabetes.

      The investigators hypothesize that vitamin D status is related to diabetes risk measured by
      hemoglobin A1c (a test of glucose level over time), fasting glucose and insulin in
      non-diabetic African American adults and that body weight status may affect vitamin D status
      in response to vitamin D supplements compared to placebo.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Participants will be randomly assigned to receive either a 60,000 IU vitamin D3 supplement
      every four weeks or an inactive placebo. All investigators and the participants will be
      blinded to the assignment group of each participant until all testing is completed.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2010</start_date>
  <completion_date type="Actual">May 2010</completion_date>
  <primary_completion_date type="Actual">May 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Fasting glucose level before, mid-way through, and after the vitamin D3 supplement or placebo trial.</measure>
    <time_frame>16 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Serum 25-OH D levels in response to vitamin D3 supplement or placebo across a range of adiposity</measure>
    <time_frame>16 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">48</enrollment>
  <condition>Type 2 Diabetes</condition>
  <arm_group>
    <arm_group_label>Vitamin D3 supplement</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>60,000 IU vitamin D3 oral supplement provided every four weeks at weeks 0, 4, 8, and 12 in the form of one 50,000 and two 5,000 IU vitamin D3 supplements in gelcap form.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sugar Pill</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Inactive placebo tablets identical in appearance to the active comparator provided every four weeks at weeks 0,4,8,and 12.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>vitamin D3, cholecalciferol</intervention_name>
    <description>1 gelcap of 50,000 IU vitamin D3 plus 2 gelcaps of 5,000 IU vitamin D3 each; a total of 60,000 IU vitamin D3 dosed four weeks apart at weeks 0, 4, 8, and 12 of the 16 week study.</description>
    <arm_group_label>Vitamin D3 supplement</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Inactive comparator</intervention_name>
    <description>The inactive comparator dose provided was identical in appearance to the active comparator but contained no vitamin D3</description>
    <arm_group_label>Sugar Pill</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  African American by self-report

          -  In good health

        Exclusion Criteria:

          -  Diagnosis of diabetes

          -  Health problems/medication affecting calcium and/or vitamin D metabolism

          -  Current use of vitamin/mineral/herbal/nutritional supplements

          -  Inability to swallow pills

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yanbin Dong, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Augusta University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Medical College of Georgia</name>
      <address>
        <city>Augusta</city>
        <state>Georgia</state>
        <zip>30912</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Liu E, Meigs JB, Pittas AG, McKeown NM, Economos CD, Booth SL, Jacques PF. Plasma 25-hydroxyvitamin d is associated with markers of the insulin resistant phenotype in nondiabetic adults. J Nutr. 2009 Feb;139(2):329-34. doi: 10.3945/jn.108.093831. Epub 2008 Dec 23.</citation>
    <PMID>19106328</PMID>
  </reference>
  <reference>
    <citation>Pittas AG, Dawson-Hughes B. Vitamin D and diabetes. J Steroid Biochem Mol Biol. 2010 Jul;121(1-2):425-9. doi: 10.1016/j.jsbmb.2010.03.042. Epub 2010 Mar 18. Review.</citation>
    <PMID>20304061</PMID>
  </reference>
  <reference>
    <citation>Voidonikola PT, Stamatelopoulos KS, Alevizaki M, Kollias GE, Zakopoulos NA, Lekakis JP, Anastasiou E, Theodorakis MJ, Pittas AG, Papamichael CM. The association between glycemia and endothelial function in nondiabetic individuals: the importance of body weight. Obesity (Silver Spring). 2008 Dec;16(12):2658-62. doi: 10.1038/oby.2008.431. Epub 2008 Oct 9.</citation>
    <PMID>18846051</PMID>
  </reference>
  <reference>
    <citation>Liu E, Meigs JB, Pittas AG, Economos CD, McKeown NM, Booth SL, Jacques PF. Predicted 25-hydroxyvitamin D score and incident type 2 diabetes in the Framingham Offspring Study. Am J Clin Nutr. 2010 Jun;91(6):1627-33. doi: 10.3945/ajcn.2009.28441. Epub 2010 Apr 14.</citation>
    <PMID>20392893</PMID>
  </reference>
  <verification_date>June 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 4, 2010</study_first_submitted>
  <study_first_submitted_qc>June 9, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 10, 2010</study_first_posted>
  <last_update_submitted>June 9, 2010</last_update_submitted>
  <last_update_submitted_qc>June 9, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 10, 2010</last_update_posted>
  <responsible_party>
    <name_title>Jennifer Pederson-White, DO</name_title>
    <organization>Medical College of Georgia</organization>
  </responsible_party>
  <keyword>vitamin D status</keyword>
  <keyword>25-OH D</keyword>
  <keyword>ionized calcium</keyword>
  <keyword>fasting glucose</keyword>
  <keyword>hemoglobin A1c</keyword>
  <keyword>fasting insulin</keyword>
  <keyword>glucose metabolism</keyword>
  <keyword>HOMA index</keyword>
  <keyword>blood lipids</keyword>
  <keyword>type 2 diabetes</keyword>
  <keyword>PTH</keyword>
  <keyword>adiposity</keyword>
  <keyword>body fat percentage</keyword>
  <keyword>dual energy x-ray absorptiometry</keyword>
  <keyword>pulse wave velocity</keyword>
  <keyword>arterial stiffness</keyword>
  <keyword>flow-mediated dilation</keyword>
  <keyword>African American</keyword>
  <keyword>inflammatory markers</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
    <mesh_term>Cholecalciferol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

